Health ❯ Healthcare ❯ Cancer Treatment

Combination Therapy

Molecular Pathways Drug Interactions Revumenib KRAS Mutations Chemotherapy Anti-PD-1 Therapy Targeted Therapy Immunotherapy Drugs Kinase Inhibitors Giredestrant and Everolimus Venetoclax and HMA Pertuzumab (Perjeta)

KOMET-007 Shows 600 mg Ziftomenib Plus Venetoclax/Azacitidine Achieves Deep Remissions in NPM1‑Mutated AML

Investigators reported early MRD clearance without added toxicity in an elderly cohort.

Roche’s Giredestrant Plus Everolimus Extends PFS in Phase 3 evERA for ER-Positive, HER2-Negative Breast Cancer

mRNA Neoantigen Vaccine Amplifies Anti-PD-1 Immunity and Suppresses Gastric Cancer Spread in Mice

Universal mRNA Vaccine Eradicates Tumors in Mice and Advances Toward Human Trials

FDA Clears MT-125 for First Human Trials in Treatment-Resistant Glioblastoma

Triplet Therapy Doubles Survival in BRAF V600E Metastatic Colorectal Cancer